Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TNFSF15 antibody

This Mouse Monoclonal antibody specifically detects TNFSF15 in IHC. It exhibits reactivity toward Human.
Catalog No. ABIN6941290
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Recombinant TNFSF15 antibody (ABIN6941290)

Target

See all TNFSF15 Antibodies
TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))

Antibody Type

Recombinant Antibody

Reactivity

  • 125
  • 39
  • 17
  • 5
  • 4
  • 4
  • 4
Human

Host

  • 78
  • 40
  • 12
  • 1
Mouse

Clonality

  • 66
  • 60
  • 4
Monoclonal

Conjugate

  • 68
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TNFSF15 antibody is un-conjugated

Application

  • 64
  • 44
  • 30
  • 27
  • 26
  • 19
  • 13
  • 13
  • 9
  • 9
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

RVEGI-1283
  • Purpose

    Recombinant TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) Antibody

    Specificity

    VEGI is an anti-angiogenic cytokine that belongs to tumor necrosis factor superfamily, member 15 (TNFSF15). This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of VEGI has been reported as a marker of poor prognosis in breast cancer.

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant human full-length VEGI protein

    Isotype

    IgG1, kappa
  • Application Notes

    Positive Control: Endothelial cells. Colon, intestine, placenta, lung, liver, kidney, pancreas, spleen and prostate.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 10-20 min followed by cooling at RT for 20 minutes) Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))

    Alternative Name

    TNFSF15

    Background

    TNF ligand-related molecule 1 (TL1A), Tumor necrosis factor (ligand) superfamily member 15 (TNFSF15), Vascular endothelial growth inhibitor 192a, Vascular endothelial growth inhibitor (VEGI), VEGI192A

    Endothelial cells. Colon, intestine, Kidney, Liver, Lung, Pancreas, Placenta, spleen or prostate.

    Molecular Weight

    22kDa

    Gene ID

    9966, 241382

    UniProt

    O95150

    Pathways

    Positive Regulation of Endopeptidase Activity, Autophagy
You are here:
Chat with us!